Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agenus Inc
(NQ:
AGEN
)
13.07
+0.55 (+4.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc
< Previous
1
2
3
4
5
6
7
Next >
Here's Why Agenus Stock Is Getting Hammered Today
October 22, 2021
The company's experimental anti-PD1 drug hit a wall.
Via
The Motley Fool
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer
September 17, 2021
Agenus Inc (NASDAQ: AGEN) presented final results from the Bal/Zal combination study at the European Society for Medical Oncology (ESMO21) Virtual Conference 2021...
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
Why Agenus Fell by Over 4% on Monday
August 09, 2021
Investors were spooked by some ugly numbers in the company's latest earnings report.
Via
The Motley Fool
Agenus inc (AGEN) Q2 2021 Earnings Call Transcript
August 09, 2021
AGEN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks That Hit 52-Week Highs On Monday
August 16, 2021
Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs. Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to set a new 52-week...
Via
Benzinga
Recap: Agenus Q2 Earnings
August 09, 2021
Shares of Agenus (NASDAQ:AGEN) moved higher by 2.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 32.14% over...
Via
Benzinga
Why Agenus Stock Sank on Tuesday
July 27, 2021
A top company executive is stepping down in the very near future.
Via
The Motley Fool
50 Biggest Movers From Yesterday
June 18, 2021
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Agenus Stock Is Marching Higher Today
June 17, 2021
The biotech took a major step toward becoming a commercial-stage cancer company.
Via
The Motley Fool
Exposures
Product Safety
34 Stocks Moving In Thursday's Mid-Day Session
June 17, 2021
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 68.5% to $5.51 after the company announced it filed a registration statement in connect with the proposed merger...
Via
Benzinga
Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer
June 17, 2021
The FDA has accepted for review Agenus Inc's (NASDAQ: AGEN) marketing application seeking approval for balstilimab for recurrent or metastatic cervical cancer...
Via
Benzinga
Exposures
Product Safety
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
June 11, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...
Via
Benzinga
75 Biggest Movers From Yesterday
June 09, 2021
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock. NextDecade...
Via
Benzinga
Why Agenus Stock Is Jumping Today
June 08, 2021
There was some positive news, but it probably wasn't a huge catalyst for the stock.
Via
The Motley Fool
Exposures
Product Safety
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
4 Biotech Stocks Wall Street Analysts Predict Will Gain More Than 60%
May 22, 2021
The integration of technology and successful clinical trials for treating critical ailments have boosted Wall Street’s optimism about several biotech stocks. Analysts expect Bionano, Cerus, Agenus and...
Via
Talk Markets
Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants
May 20, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
May 19, 2021
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.
Via
The Motley Fool
Exposures
COVID-19
Why Agenus Stock Skyrocketed Today
May 18, 2021
The biotech announced a big licensing deal with Bristol Myers Squibb.
Via
The Motley Fool
58 Biggest Movers From Yesterday
May 19, 2021
Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Turns Negative; Ultralife Shares Spike Higher
May 18, 2021
Toward the end of trading Tuesday, the Dow traded down 0.39% to 34,192.78 while the NASDAQ fell 0.11% to 13,364.14. The S&P also fell, dropping 0.42% to 4,145.60. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 18, 2021
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Mid-Day Market Update: TOMI Environmental Solutions Falls After Q1 Results; Agenus Shares Jump
May 18, 2021
Midway through trading Tuesday, the Dow traded down 0.16% to 34,272.59 while the NASDAQ rose 0.69% to 13,470.97. The S&P also rose, gaining 0.03% to 4,164.63. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
42 Stocks Moving In Tuesday's Mid-Day Session
May 18, 2021
Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.